StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Worldwide foreign exchange impact YoY by Year

Worldwide foreign exchange impact YoY (%) (%)

Eli Lilly Worldwide foreign exchange impact YoY: 1.0% in FY2025.

Latest, FY2025
1.0%
Period ended Dec 31, 2025
Change on a year earlier
–
History
5 years
Since FY2018
Sources
5
Documents cited below

Where the FY2025 figure comes from

“|| Foreign exchange rates | — | % | 2 | % | 1 | %”

Source: Form 10-K FY2025 (filed 2026-02-12) ↗

Reported in Form 10-Q / 10-K MD&A & Form 8-K Q4 Releases.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWorldwide foreign exchange impact YoY (%) (%)Year on yearSource
FY2025Dec 31, 20251.0%–Form 10-K FY2025 (filed 2026-02-12) ↗
FY2022Dec 31, 2022-3.0%-4.0 ptsForm 10-K FY2022 (filed 2023-02-22) ↗
FY2021Dec 31, 20211.0%–Form 10-K FY2021 (filed 2022-02-23) ↗
FY2019Dec 31, 2019-1.0%-2.0 ptsForm 10-K FY2019 (filed 2020-02-19) ↗
FY2018Dec 31, 20181.0%–Form 10-K FY2018 (filed 2019-02-19) ↗

Cite this data

StockData. (2026). Eli Lilly Worldwide foreign exchange impact YoY (%), annual FY2018–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-ww-fx

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.